| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |